# Ambisome in Liver Transplant Patients

> **NCT00161356** · PHASE4 · TERMINATED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 10 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** Ambisome
- **PROCEDURE:** Liver Biopsy

## Key facts

- **NCT ID:** NCT00161356
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Budget issues
- **Last updated:** 2008-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00161356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00161356, "Ambisome in Liver Transplant Patients". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00161356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*